Protein kinase C beta (PKCβ) in malignant pleural mesothelioma

PURPOSE: Malignant pleural mesothelioma (MPM) is a disease with few therapeutic options. Protein kinase C beta (PKCß) is involved in important cellular functions. Enzastaurin (LY317615.HCl) is a novel inhibitor of PKC in clinical development. EXPERIMENTAL DESIGN: MPM cell lines (7) and patient tumor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Faoro, Leonardo, Loganathan, Sivakumar, Westerhoff, Maria, Modi, Rahul, Husain, Aliya N., Tretiakova, Maria, Seiwert, Tanguy, Kindler, Hedy L., Vokes, Everett E., Salgia, Ravi
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2605682/
https://ncbi.nlm.nih.gov/pubmed/18765998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0b013e32830ce506
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars